Skip to main content
SpringerLink
Log in

Neurobiological Principles: Psycho-Neuro-Immuno-Endocrinology

  • Reference work entry
  • First Online:
NeuroPsychopharmacotherapy

  • 171 Accesses

Abstract

Mental disorders have a complex pathophysiology that remains only partially understood. In addition to changes in neurotransmitter systems and receptors – the effector systems that act on downstream signal transduction processes – there is increasing evidence that immunological mechanisms play an important role in the pathophysiology of mental disorders. In recent decades, psycho-neuro-immuno-endocrinology, which is concerned with the relationships between mental functions, psychiatric disorders, the immune system, and endocrine mechanisms, has become an important topic in psychiatry. Meanwhile, initial attempts have been made to make use of such psycho-neuro-immunological mechanisms as novel treatment strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 949.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,399.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Abbasi SH, Hosseini F, Modabbernia A, Ashrafi M, Akhondzadeh S. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study. J Affect Disord. 2012;141:308–14.

    CAS  PubMed  Google Scholar 

  • Ader R, Felten DL. Psychoneuroimmunology. San Diego/New York/Toronto: Academic Press; 1991.

    Google Scholar 

  • Ahuja N, Carroll BT. Possible anti-catatonic effects of minocycline in patients with schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2007;31:968–9.

    CAS  Google Scholar 

  • Akhondzadeh S, Tabatabaee M, Amini H, Ahmadi Abhari SA, Abbasi SH, Behnam B. Celecoxib as adjunctive therapy in schizophrenia: a double-blind, randomized and placebo-controlled trial. Schizophr Res. 2007;90:179–85.

    PubMed  Google Scholar 

  • Akhondzadeh S, Jafari S, Raisi F, Ghoreishi A. A clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Paper presented at the WPA Section on Immunology and psychiatry – psychoneuroimmunology training workshop, Seeon, Munich, 11–13 July 2008.

    Google Scholar 

  • Alonso R, Chaudieu I, Diorio J, Krishnamurthy A, Quirion R, Boksa P. Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells. J Neurochem. 1993;61:1284–90.

    CAS  PubMed  Google Scholar 

  • Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2010;67:146–54.

    CAS  PubMed  Google Scholar 

  • Araujo DM, Lapchak PA, Chabot JG, Nair NP, Quirion R. Characterization and possible role of growth factor and lymphokine receptors in the regulation of cholinergic function in the mammalian brain. Prog Clin Biol Res. 1989;317:423–36.

    CAS  PubMed  Google Scholar 

  • Arolt V, Rothermundt M, Wandinger KP, Kirchner H. Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment. Mol Psychiatry. 2000;5:150–8.

    CAS  PubMed  Google Scholar 

  • Avgustin B, Wraber B, Tavcar R. Increased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia. Croat Med J. 2005;46:268–74.

    PubMed  Google Scholar 

  • Baker GA, Santalo R, Blumenstein J. Effect of psychotropic agents upon the blastogenic response of human t-lymphocytes. Biol Psychiatry. 1977;12:159–69.

    CAS  PubMed  Google Scholar 

  • Balschun D, Wetzel W, Del Rey A, Pitossi F, Schneider H, Zuschratter W, et al. Interleukin-6: a cytokine to forget. FASEB J. 2004;18:1788–90.

    CAS  PubMed  Google Scholar 

  • Bechter K, Reiber H, Herzog S, Fuchs D, Tumani H, Maxeiner HG. Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction. J Psychiatr Res. 2010;44:321–30.

    CAS  PubMed  Google Scholar 

  • Benicky J, Sanchez-Lemus E, Honda M, Pang T, Orecna M, Wang J, et al. Angiotensin II AT1 receptor blockade ameliorates brain inflammation. Neuropsychopharmacology. 2011;36:857–70.

    CAS  PubMed  Google Scholar 

  • Benros ME, Mortensen PB, Eaton WW. Autoimmune diseases and infections as risk factors for schizophrenia. Ann N Y Acad Sci. 2012;1262:56–66.

    PubMed  Google Scholar 

  • Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Phys. 1992;263:C1–16.

    CAS  Google Scholar 

  • Berrios GE, Quemada JI. Depressive illness in multiple sclerosis. Clinical and theoretical aspects of the association. Br J Psychiatry. 1990;156:10–6.

    CAS  PubMed  Google Scholar 

  • Bertini R, Garattini S, Delgado R, Ghezzi P. Pharmacological activities of chlorpromazine involved in the inhibition of tumour necrosis factor production in vivo in mice. Immunology. 1993;79:217–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Besedovsky H, del Rey A, Sorkin E, Dinarello CA. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science. 1986;233:652–4.

    CAS  PubMed  Google Scholar 

  • Blum-Degen D, Muller T, Kuhn W, Gerlach M, Przuntek H, Riederer P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer’s and de novo Parkinson’s disease patients. Neurosci Lett. 1995;202:17–20.

    CAS  PubMed  Google Scholar 

  • Bohar Z, Toldi J, Fulop F, Vecsei L. Changing the face of kynurenines and neurotoxicity: therapeutic considerations. Int J Mol Sci. 2015;16:9772–93.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Boros FA, Bohar Z, Vecsei L. Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases. Mutat Res. 2018;776:32–45.

    CAS  Google Scholar 

  • Braida D, Sacerdote P, Panerai AE, Bianchi M, Aloisi AM, Iosue S, et al. Cognitive function in young and adult IL (interleukin)-6 deficient mice. Behav Brain Res. 2004;153:423–9.

    CAS  PubMed  Google Scholar 

  • Bresee C, Rapaport MH. Persistently increased serum soluble interleukin-2 receptors in continuously ill patients with schizophrenia. Int J Neuropsychopharmacol. 2009;12:861–5.

    CAS  PubMed  Google Scholar 

  • Brown AS, Hooton J, Schaefer CA, Zhang H, Petkova E, Babulas V, et al. Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry. 2004;161:889–95.

    PubMed  Google Scholar 

  • Bruce LC, Peebles AMS. Clinical and experimental observations in catatonia. J Ment Sci. 1903;49:614–28.

    Google Scholar 

  • Brunello N, Alboni S, Capone G, Benatti C, Blom JM, Tascedda F, et al. Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression. Int Clin Psychopharmacol. 2006;21:219–25.

    PubMed  Google Scholar 

  • Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology. 2002;26:643–52.

    CAS  PubMed  Google Scholar 

  • Casolini P, Catalani A, Zuena AR, Angelucci L. Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat. J Neurosci Res. 2002;68:337–43.

    CAS  PubMed  Google Scholar 

  • Chaudhry IB, Hallak J, Husain N, Minhas F, Stirling J, Richardson P, et al. Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment. J Psychopharmacol. 2012;26:1185–93.

    PubMed  Google Scholar 

  • Chittiprol S, Venkatasubramanian G, Neelakantachar N, Babu SV, Reddy NA, Shetty KT, et al. Oxidative stress and neopterin abnormalities in schizophrenia: a longitudinal study. J Psychiatr Res. 2010;44:310–3.

    PubMed  Google Scholar 

  • Cumiskey D, Curran BP, Herron CE, O’Connor JJ. A role for inflammatory mediators in the IL-18 mediated attenuation of LTP in the rat dentate gyrus. Neuropharmacology. 2007;52:1616–23.

    CAS  PubMed  Google Scholar 

  • Dameshek W. White blood cells in dementia praecox and dementia paralytica. Arch Neurol Psychiatr. 1930;24:855.

    Google Scholar 

  • DeLisi LE, Goodman S, Neckers LM, Wyatt RJ. An analysis of lymphocyte subpopulations in schizophrenic patients. Biol Psychiatry. 1982;17:1003–9.

    CAS  PubMed  Google Scholar 

  • DeLisi LE, Weber RJ, Pert CB. Are there antibodies against brain in sera from schizophrenic patients? Review and prospectus. Biol Psychiatry. 1985;20:110–5.

    CAS  PubMed  Google Scholar 

  • Denicoff KD, Rubinow DR, Papa MZ, Simpson C, Seipp CA, Lotze MT, et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med. 1987;107:293–300.

    CAS  PubMed  Google Scholar 

  • Denney DR, Stephenson LA, Penick EC, Weller RA. Lymphocyte subclasses and depression. J Abnorm Psychol. 1988;97:499–502.

    CAS  PubMed  Google Scholar 

  • Duch DS, Woolf JH, Nichol CA, Davidson JR, Garbutt JC. Urinary excretion of biopterin and neopterin in psychiatric disorders. Psychiatry Res. 1984;11:83–9.

    CAS  PubMed  Google Scholar 

  • Ellman LM, Deicken RF, Vinogradov S, Kremen WS, Poole JH, Kern DM, Tsai WY, Schaefer CA, Brown AS.Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8.Schizophr Res. 2010;121(1–3):46–54. https://doi.org/10.1016/j.schres.2010.05.014. Epub 2010 Jun 9

  • Eikelenboom P, Rozemuller JM, Kraal G, Stam FC, McBride PA, Bruce ME, et al. Cerebral amyloid plaques in Alzheimer’s disease but not in scrapie-affected mice are closely associated with a local inflammatory process. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;60:329–36.

    CAS  PubMed  Google Scholar 

  • Frank MG, Baratta MV, Sprunger DB, Watkins LR, Maier SF. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun. 2007;21:47–59.

    CAS  PubMed  Google Scholar 

  • Furukawa H, del Rey A, Monge-Arditi G, Besedovsky HO. Interleukin-1, but not stress, stimulates glucocorticoid output during early postnatal life in mice. Ann N Y Acad Sci. 1998;840:117–22.

    CAS  PubMed  Google Scholar 

  • Gimeno D, Marmot MG, Singh-Manoux A. Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study. Psychoneuroendocrinology. 2008;33:1322–34.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21:1696–709.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Gossec L, Steinberg G, Rouanet S, Combe B. Fatigue in rheumatoid arthritis: quantitative findings on the efficacy of tocilizumab and on factors associated with fatigue. The French multicentre prospective PEPS study. Clin Exp Rheumatol. 2015;33:664–70.

    PubMed  Google Scholar 

  • Grosskopf A, Muller N, Malo A, Wank R. Potential role for the narcolepsy- and multiple sclerosis-associated HLA allele DQB1∗0602 in schizophrenia subtypes. Schizophr Res. 1998;30:187–9.

    CAS  PubMed  Google Scholar 

  • Gruber L, Bunse T, Weidinger E, Reichard H, Muller N. Adjunctive recombinant human interferon gamma-1b for treatment-resistant schizophrenia in 2 patients. J Clin Psychiatry. 2014;75:1266–7.

    PubMed  Google Scholar 

  • Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kuhn M, Schuld A, et al. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis. J Psychiatr Res. 1999;33:407–18.

    CAS  PubMed  Google Scholar 

  • Hafner S, Baghai TC, Eser D, Schule C, Rupprecht R, Bondy B, et al. C-reactive protein is associated with polymorphisms of the angiotensin-converting enzyme gene in major depressed patients. J Psychiatr Res. 2008;42:163–5.

    PubMed  Google Scholar 

  • Hampel H, Schwarz MJ, Kötter HU, Schneider C, Müller N. Cell adhesion molecules in the central nervous system: significance and therapeutic perspectives in neuropsychiatric disorders. Drug News Perspect. 1996;9:69–81.

    CAS  Google Scholar 

  • Hampel H, Kotter HU, Padberg F, Korschenhausen DA, Moller HJ. Oligoclonal bands and blood--cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis. Alzheimer Dis Assoc Disord. 1999;13:9–19.

    CAS  PubMed  Google Scholar 

  • Hayley S, Wall P, Anisman H. Sensitization to the neuroendocrine, central monoamine and behavioural effects of murine tumor necrosis factor-alpha: peripheral and central mechanisms. Eur J Neurosci. 2002;15:1061–76.

    CAS  PubMed  Google Scholar 

  • Henneberg A, Riedl B, Dumke HO, Kornhuber HH. T-lymphocyte subpopulations in schizophrenic patients. Eur Arch Psychiatry Neurol Sci. 1990;239:283–4.

    CAS  PubMed  Google Scholar 

  • Herbert TB, Cohen S. Depression and immunity: a meta-analytic review. Psychol Bull. 1993;113:472–86.

    CAS  PubMed  Google Scholar 

  • Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci U S A. 1997;94:1500–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Irwin M, Smith TL, Gillin JC. Low natural killer cytotoxicity in major depression. Life Sci. 1987;41:2127–33.

    CAS  PubMed  Google Scholar 

  • Kappelmann N, Lewis G, Dantzer R, Jones PB, Khandaker GM. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol Psychiatry. 2018;23:335–43.

    CAS  PubMed  Google Scholar 

  • Kipnis J, Cohen H, Cardon M, Ziv Y, Schwartz M. T cell deficiency leads to cognitive dysfunction: implications for therapeutic vaccination for schizophrenia and other psychiatric conditions. Proc Natl Acad Sci U S A. 2004;101:8180–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Knight JG. Dopamine-receptor-stimulating autoantibodies: a possible cause of schizophrenia. Lancet. 1982;2:1073–6.

    CAS  PubMed  Google Scholar 

  • Kohler O, Benros ME, Nordentoft M, Farkouh ME, Iyengar RL, Mors O, et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiat. 2014;71:1381–91.

    Google Scholar 

  • Kohler O, Gasse C, Petersen L, Ingstrup KG, Nierenberg AA, Mors O, et al. The effect of concomitant treatment with SSRIs and statins: a population-based study. Am J Psychiatry. 2016;173:807–15.

    PubMed  Google Scholar 

  • Korte S, Arolt V, Peters M, Weitzsch C, Rothermundt M, Kirchner H. Increased serum neopterin levels in acutely ill and recovered schizophrenic patients. Schizophr Res. 1998;32:63–7.

    CAS  PubMed  Google Scholar 

  • Kurtz G, Muller N. The antiphospholipid syndrome and psychosis. Am J Psychiatry. 1994;151:1841–2.

    CAS  PubMed  Google Scholar 

  • Laan W, Grobbee DE, Selten JP, Heijnen CJ, Kahn RS, Burger H. Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2010;71:520–7.

    CAS  PubMed  Google Scholar 

  • Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology. 2000;22:370–9.

    CAS  PubMed  Google Scholar 

  • Lapchak PA. A role for interleukin-2 in the regulation of striatal dopaminergic function. Neuroreport. 1992;3:165–8.

    CAS  PubMed  Google Scholar 

  • Lehmann-Facius H. Serologisch-analytische Versuche mit Liquores und Seren von Schizophrenen. Allg Z Psychiatrie. 1939;110:232–43.

    Google Scholar 

  • Levkovitz Y, Mendlovich S, Riwkes S, Braw Y, Levkovitch-Verbin H, Gal G, et al. A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry. 2010;71:138–49.

    CAS  PubMed  Google Scholar 

  • Levy EM, Borrelli DJ, Mirin SM, Salt P, Knapp PH, Peirce C, et al. Biological measures and cellular immunological function in depressed psychiatric inpatients. Psychiatry Res. 1991;36:157–67.

    CAS  PubMed  Google Scholar 

  • Lewandowski G, Hobbs MV, Bloom FE. Alteration of intracerebral cytokine production in mice infected with herpes simplex virus types 1 and 2. J Neuroimmunol. 1994;55:23–34.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH. Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am J Psychiatry. 1993;150:1408–10.

    CAS  PubMed  Google Scholar 

  • Lieberman AP, Pitha PM, Shin HS, Shin ML. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci U S A. 1989;86:6348–52.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuro-Psychopharmacol Biol Psychiatry. 1995;19:11–38.

    CAS  Google Scholar 

  • Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res. 1995a;29:141–52.

    CAS  PubMed  Google Scholar 

  • Maes M, Bosmans E, Meltzer HY. Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol. Eur Arch Psychiatry Clin Neurosci. 1995b;245:172–8.

    CAS  PubMed  Google Scholar 

  • Maes M, Bosmans E, Kenis G, De Jong R, Smith RS, Meltzer HY. In vivo immunomodulatory effects of clozapine in schizophrenia. Schizophr Res. 1997;26:221–5.

    CAS  PubMed  Google Scholar 

  • Maes M, Anderson G, Kubera M, Berk M. Targeting classical IL-6 signalling or IL-6 trans-signalling in depression? Expert Opin Ther Targets. 2014;18:495–512.

    CAS  PubMed  Google Scholar 

  • McAllister CG, Rapaport MH, Pickar D, Paul SM. Effects of short-term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients. Arch Gen Psychiatry. 1989a;46:956–7.

    CAS  PubMed  Google Scholar 

  • McAllister CG, Rapaport MH, Pickar D, Podruchny TA, Christison G, Alphs LD, et al. Increased numbers of CD5+ B lymphocytes in schizophrenic patients. Arch Gen Psychiatry. 1989b;46:890–4.

    CAS  PubMed  Google Scholar 

  • McAllister CG, van Kammen DP, Rehn TJ, Miller AL, Gurklis J, Kelley ME, et al. Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status. Am J Psychiatry. 1995;152:1291–7.

    CAS  PubMed  Google Scholar 

  • McGeer PL, Rogers J, McGeer EG. Inflammation, antiinflammatory agents, and Alzheimer’s disease: the last 22 years. J Alzheimers Dis. 2016;54:853–7.

    PubMed  Google Scholar 

  • Melnikova T, Savonenko A, Wang Q, Liang X, Hand T, Wu L, et al. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer’s disease in a sex-dimorphic pattern. Neuroscience. 2006;141:1149–62.

    CAS  PubMed  Google Scholar 

  • Merrill JE. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci. 1992;14:1–10.

    CAS  PubMed  Google Scholar 

  • Miller BJ, Buckley PF. The case for adjunctive monoclonal antibody immunotherapy in schizophrenia. Psychiatr Clin North Am. 2016;39:187–98.

    PubMed  Google Scholar 

  • Miller AH, Lackner C. Tricyclic antidepressants and immunity. In: Miller AH, editor. Depressive disorders and immunity. Washington: American Psychiatric Press; 1989.

    Google Scholar 

  • Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011;70:663–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000;164:6166–73.

    CAS  PubMed  Google Scholar 

  • Mittleman BB, Castellanos FX, Jacobsen LK, Rapoport JL, Swedo SE, Shearer GM. Cerebrospinal fluid cytokines in pediatric neuropsychiatric disease. J Immunol. 1997;159:2994–9.

    CAS  PubMed  Google Scholar 

  • Mizoguchi H, Takuma K, Fukakusa A, Ito Y, Nakatani A, Ibi D, et al. Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice. Psychopharmacology. 2008;196:233–41.

    CAS  PubMed  Google Scholar 

  • Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, et al. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett. 1994a;180:147–50.

    CAS  PubMed  Google Scholar 

  • Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T. Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett. 1994b;165:208–10.

    CAS  PubMed  Google Scholar 

  • Mogi M, Harada M, Kondo T, Narabayashi H, Riederer P, Nagatsu T. Transforming growth factor-beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson’s disease. Neurosci Lett. 1995a;193:129–32.

    CAS  PubMed  Google Scholar 

  • Mogi M, Harada M, Kondo T, Riederer P, Nagatsu T. Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson’s disease. J Neural Transm Park Dis Dement Sect. 1995b;9:87–92.

    CAS  PubMed  Google Scholar 

  • Molholm HB. Hyposensitivity to foreign protein in schizophrenic patients. Psychiatr Q. 1942;16:565–71.

    Google Scholar 

  • Müller N. Psychoneuroimmunology: implications for the drug treatment of psychiatric disorders. CNS Drugs. 1995;4:125–40.

    Google Scholar 

  • Muller N. COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence. Curr Opin Investig Drugs. 2010;11:31–42.

    PubMed  Google Scholar 

  • Müller N. Immunologische Behandlungsoptionen bei schizophrenen Störungen. Fortschr Neurol Psychiatr. 2013;82:210–9.

    Google Scholar 

  • Muller N. The role of intercellular adhesion molecule-1 in the pathogenesis of psychiatric disorders. Front Pharmacol. 2019;10:1251.

    PubMed  PubMed Central  Google Scholar 

  • Muller N, Ackenheil M. The immune system and schizophrenia. In: Leonard BE, Miller K, editors. Stress, the immune system and psychiatry. New York/Chichester: Wiley; 1995a. p. 137–64.

    Google Scholar 

  • Muller N, Ackenheil M. Immunoglobulin and albumin content of cerebrospinal fluid in schizophrenic patients: relationship to negative symptomatology. Schizophr Res. 1995b;14:223–8.

    CAS  PubMed  Google Scholar 

  • Muller N, Ackenheil M. Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog Neuro-Psychopharmacol Biol Psychiatry. 1998;22:1–33.

    CAS  Google Scholar 

  • Müller N, Bechter K. The mild encephalitis concept for psychiatric disorders revisited in the light of current psychoneuroimmunological findings. Neurol Psychiatry Brain Res. 2013;19:87–101.

    Google Scholar 

  • Muller N, Schwarz MJ. The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view. J Neural Transm. 2007;(Suppl 72):269–80.

    Google Scholar 

  • Muller N, Schwarz MJ. Immune system and Schizophrenia. Curr Immunol Rev. 2010;6:213–20.

    PubMed  PubMed Central  Google Scholar 

  • Muller N, Ackenheil M, Hofschuster E, Mempel W, Eckstein R. Cellular immunity in schizophrenic patients before and during neuroleptic treatment. Psychiatry Res. 1991;37:147–60.

    CAS  PubMed  Google Scholar 

  • Muller N, Gizycki-Nienhaus B, Gunther W, Meurer M. Depression as a cerebral manifestation of scleroderma: immunological findings in serum and cerebrospinal fluid. Biol Psychiatry. 1992;31:1151–6.

    CAS  PubMed  Google Scholar 

  • Muller N, Empl M, Riedel M, Schwarz M, Ackenheil M. Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 1997;247:308–13.

    CAS  PubMed  Google Scholar 

  • Muller N, Riedel M, Hadjamu M, Schwarz MJ, Ackenheil M, Gruber R. Increase in expression of adhesion molecule receptors on T helper cells during antipsychotic treatment and relationship to blood-brain barrier permeability in schizophrenia. Am J Psychiatry. 1999;156:634–6.

    CAS  PubMed  Google Scholar 

  • Muller N, Riedel M, Scheppach C, Brandstatter B, Sokullu S, Krampe K, et al. Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry. 2002;159:1029–34.

    PubMed  Google Scholar 

  • Muller N, Riedel M, Schwarz MJ, Engel RR. Clinical effects of COX-2 inhibitors on cognition in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2005a;255:149–51.

    PubMed  Google Scholar 

  • Muller N, Schwarz MJ, Riedel M. COX-2 inhibition in schizophrenia: focus on clinical effects of celecoxib therapy and the role of TNF-alpha. In: Eaton WW, editor. Medical and psychiatric comorbidity over the course of life. Washington, DC: American Psychiatric Publishing; 2005b. p. 265–76.

    Google Scholar 

  • Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B, et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry. 2006;11:680–4.

    CAS  PubMed  Google Scholar 

  • Muller N, Krause D, Dehning S, Musil R, Schennach-Wolff R, Obermeier M, et al. Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment. Schizophr Res. 2010;121:118–24.

    PubMed  Google Scholar 

  • Muller N, Myint AM, Schwarz MJ. Immunological treatment options for schizophrenia. Curr Pharm Biotechnol. 2012a;13:1606–13.

    PubMed  Google Scholar 

  • Muller N, Myint AM, Schwarz MJ. Inflammation in schizophrenia. Adv Protein Chem Struct Biol. 2012b;88:49–68.

    PubMed  Google Scholar 

  • Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metab. 2002;3:175–87.

    CAS  PubMed  Google Scholar 

  • Myint AM, Steinbusch HW, Goeghegan L, Luchtman D, Kim YK, Leonard BE. Effect of the COX-2 inhibitor celecoxib on behavioural and immune changes in an olfactory bulbectomised rat model of depression. Neuroimmunomodulation. 2007;14:65–71.

    CAS  PubMed  Google Scholar 

  • Na KS, Lee KJ, Lee JS, Cho YS, Jung HY. Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis. Prog Neuro-Psychopharmacol Biol Psychiatry. 2014;48:79–85.

    CAS  Google Scholar 

  • Nair A, Bonneau RH. Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation. J Neuroimmunol. 2006;171:72–85.

    CAS  PubMed  Google Scholar 

  • Nemni R, Iannaccone S, Quattrini A, Smirne S, Sessa M, Lodi M, et al. Effect of chronic treatment with recombinant interleukin-2 on the central nervous system of adult and old mice. Brain Res. 1992;591:248–52.

    CAS  PubMed  Google Scholar 

  • Nikkila HV, Muller K, Ahokas A, Rimon R, Andersson LC. Increased frequency of activated lymphocytes in the cerebrospinal fluid of patients with acute schizophrenia. Schizophr Res. 2001;49:99–105.

    CAS  PubMed  Google Scholar 

  • Nistico G, De Sarro G. Is interleukin 2 a neuromodulator in the brain? Trends Neurosci. 1991;14:146–50.

    CAS  PubMed  Google Scholar 

  • Nitta M, Kishimoto T, Muller N, Weiser M, Davidson M, Kane JM, et al. Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Schizophr Bull. 2013;39:1230–41.

    PubMed  PubMed Central  Google Scholar 

  • Norris JG, Benveniste EN. Interleukin-6 production by astrocytes: induction by the neurotransmitter norepinephrine. J Neuroimmunol. 1993;45:137–45.

    CAS  PubMed  Google Scholar 

  • Ogawa A, Yoshizaki A, Yanaba K, Ogawa F, Hara T, Muroi E, et al. The differential role of L-selectin and ICAM-1 in Th1-type and Th2-type contact hypersensitivity. J Invest Dermatol. 2010;130:1558–70.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Pennisi E. Neuroimmunology. Tracing molecules that make the brain-body connection. Science. 1997;275:930–1.

    CAS  PubMed  Google Scholar 

  • Plangar I, Majlath Z, Vecsei L. Kynurenines in cognitive functions: their possible role in depression. Neuropsychopharmacol Hung. 2012;14:239–44.

    PubMed  Google Scholar 

  • Plata-Salaman CR. Immunoregulators in the nervous system. Neurosci Biobehav Rev. 1991;15:185–215.

    CAS  PubMed  Google Scholar 

  • Pollmacher T, Hinze-Selch D, Mullington J, Holsboer F. Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors. Arch Gen Psychiatry. 1995;52:877–8.

    CAS  PubMed  Google Scholar 

  • Pollmacher T, Schuld A, Kraus T, Haack M, Hinze-Selch D. On the clinical relevance of clozapine-triggered release of cytokines and soluble cytokine-receptors. Fortschr Neurol Psychiatr. 2001;69(Suppl 2):S65–74.

    PubMed  Google Scholar 

  • Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry. 2008;63:801–8.

    CAS  PubMed  Google Scholar 

  • Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, Sullivan PF, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748–52.

    CAS  PubMed  Google Scholar 

  • Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiat. 2013;70:31–41.

    CAS  Google Scholar 

  • Rapaport MH, Delrahim KK, Bresee CJ, Maddux RE, Ahmadpour O, Dolnak D. Celecoxib augmentation of continuously ill patients with schizophrenia. Biol Psychiatry. 2005;57:1594–6.

    CAS  PubMed  Google Scholar 

  • Riedel M, Spellmann I, Schwarz MJ, Strassnig M, Sikorski C, Moller HJ, et al. Decreased T cellular immune response in schizophrenic patients. J Psychiatr Res. 2007;41:3–7.

    PubMed  Google Scholar 

  • Ross BM, Seguin J, Sieswerda LE. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis. 2007;6:21.

    PubMed  PubMed Central  Google Scholar 

  • Rothermundt M, Arolt V, Fenker J, Gutbrodt H, Peters M, Kirchner H. Different immune patterns in melancholic and non-melancholic major depression. Eur Arch Psychiatry Clin Neurosci. 2001;251:90–7.

    CAS  PubMed  Google Scholar 

  • Saavedra JM, Sanchez-Lemus E, Benicky J. Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: therapeutic implications. Psychoneuroendocrinology. 2011;36:1–18.

    CAS  PubMed  Google Scholar 

  • Sandrini M, Vitale G, Pini LA. Effect of rofecoxib on nociception and the serotonin system in the rat brain. Inflamm Res. 2002;51:154–9.

    CAS  PubMed  Google Scholar 

  • Schennach H, Murr C, Gachter E, Mayersbach P, Schonitzer D, Fuchs D. Factors influencing serum neopterin concentrations in a population of blood donors. Clin Chem. 2002;48:643–5.

    CAS  PubMed  Google Scholar 

  • Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7.

    PubMed Central  Google Scholar 

  • Schwarz MJ, Ackenheil M, Riedel M, Muller N. Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia. Neurosci Lett. 1998;253:201–3.

    CAS  PubMed  Google Scholar 

  • Schwarz MJ, Riedel M, Ackenheil M, Muller N. Decreased levels of soluble intercellular adhesion molecule-1 (sICAM-1) in unmedicated and medicated schizophrenic patients. Biol Psychiatry. 2000;47:29–33.

    CAS  PubMed  Google Scholar 

  • Schwieler L, Erhardt S, Erhardt C, Engberg G. Prostaglandin-mediated control of rat brain kynurenic acid synthesis--opposite actions by COX-1 and COX-2 isoforms. J Neural Transm (Vienna). 2005;112:863–72.

    CAS  PubMed  Google Scholar 

  • Schwieler L, Larsson MK, Skogh E, Kegel ME, Orhan F, Abdelmoaty S, et al. Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia – significance for activation of the kynurenine pathway. J Psychiatry Neurosci. 2015;40:126–33.

    PubMed  PubMed Central  Google Scholar 

  • Seidel A, Arolt V, Hunstiger M, Rink L, Behnisch A, Kirchner H. Major depressive disorder is associated with elevated monocyte counts. Acta Psychiatr Scand. 1996;94:198–204.

    CAS  PubMed  Google Scholar 

  • Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe’er I, et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature. 2009;460:753–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci. 1995;762:474–6.

    CAS  PubMed  Google Scholar 

  • Soliven B, Albert J. Tumor necrosis factor modulates the inactivation of catecholamine secretion in cultured sympathetic neurons. J Neurochem. 1992;58:1073–8.

    CAS  PubMed  Google Scholar 

  • Sommer IE, de Witte L, Begemann M, Kahn RS. Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis. J Clin Psychiatry. 2012;73:414–9.

    CAS  PubMed  Google Scholar 

  • Sommer IE, van Westrhenen R, Begemann MJ, de Witte LD, Leucht S, Kahn RS. Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. Schizophr Bull. 2014;40:181–91.

    PubMed  Google Scholar 

  • Song C, Leonard BE. An acute phase protein response in the olfactory bulbectomised rat: effect of sertraline treatment. Med Sci Res. 1994;22:313–4.

    CAS  Google Scholar 

  • Sparkman NL, Johnson RW. Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation. 2008;15:323–30.

    CAS  PubMed  Google Scholar 

  • Spellberg B, Edwards JE Jr. Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis. 2001;32:76–102.

    CAS  PubMed  Google Scholar 

  • Sperner-Unterweger B, Gaggl S, Fleischhacker WW, Barnas C, Herold M, Geissler D. Effects of clozapine on hematopoiesis and the cytokine system. Biol Psychiatry. 1993;34:536–43.

    CAS  PubMed  Google Scholar 

  • Sperner-Unterweger B, Miller C, Holzner B, Widner B, Fleischhacker WW, Fuchs D. Measurement of neopterin, kynurenine and tryptophan in sera of schizophrenic patients. In: Müller N, editor. Psychiatry, psychoimmunology, and viruses. Vienna/New York: Springer; 1999. p. 115–9.

    Google Scholar 

  • Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, et al. Common variants conferring risk of schizophrenia. Nature. 2009;460:744–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Stevens JR. Schizophrenia and multiple sclerosis. Schizophr Bull. 1988;14:231–41.

    CAS  PubMed  Google Scholar 

  • Swerdlow NR, van Bergeijk DP, Bergsma F, Weber E, Talledo J. The effects of memantine on prepulse inhibition. Neuropsychopharmacology. 2009;34:1854–64.

    CAS  PubMed  Google Scholar 

  • Syvalahti E, Eskola J, Ruuskanen O, Laine T. Nonsuppression of cortisol in depression and immune function. Prog Neuro-Psychopharmacol Biol Psychiatry. 1985;9:413–22.

    CAS  Google Scholar 

  • Teunissen CE, van Boxtel MP, Bosma H, Bosmans E, Delanghe J, De Bruijn C, et al. Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol. 2003;134:142–50.

    CAS  PubMed  Google Scholar 

  • Traki L, Rostom S, Tahiri L, Bahiri R, Harzy T, Abouqal R, et al. Responsiveness of the EuroQol EQ-5D and Hospital Anxiety and Depression Scale (HADS) in rheumatoid arthritis patients receiving tocilizumab. Clin Rheumatol. 2014;33:1055–60.

    CAS  PubMed  Google Scholar 

  • Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet. 2006;367:29–35.

    CAS  PubMed  Google Scholar 

  • Varga G, Nippe N, Balkow S, Peters T, Wild MK, Seeliger S, et al. LFA-1 contributes to signal I of T-cell activation and to the production of T(h)1 cytokines. J Invest Dermatol. 2010;130:1005–12.

    CAS  PubMed  Google Scholar 

  • Vecsei L, Szalardy L, Fulop F, Toldi J. Kynurenines in the CNS: recent advances and new questions. Nat Rev Drug Discov. 2013;12:64–82.

    CAS  PubMed  Google Scholar 

  • Wagner-Jauregg J. Fieberbehandlung bei Psychosen. Wien Med Wochenschr. 1926;76:79–82.

    Google Scholar 

  • Wang AK, Miller BJ. Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression. Schizophr Bull. 2018;44:75–83.

    PubMed  Google Scholar 

  • Weitz-Schmidt G. Statins as anti-inflammatory agents. Trends Pharmacol Sci. 2002;23:482–6.

    CAS  PubMed  Google Scholar 

  • Wilke I, Arolt V, Rothermundt M, Weitzsch C, Hornberg M, Kirchner H. Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. Eur Arch Psychiatry Clin Neurosci. 1996;246:279–84.

    CAS  PubMed  Google Scholar 

  • Yang C, Hashimoto K. Peripheral IL-6 signaling: a promising therapeutic target for depression? Expert Opin Investig Drugs. 2015;24:989–90.

    CAS  PubMed  Google Scholar 

  • Yang C, Shirayama Y, Zhang JC, Ren Q, Hashimoto K. Peripheral interleukin-6 promotes resilience versus susceptibility to inescapable electric stress. Acta Neuropsychiatr. 2015a;27:312–6.

    PubMed  Google Scholar 

  • Yang JJ, Wang N, Yang C, Shi JY, Yu HY, Hashimoto K. Serum interleukin-6 is a predictive biomarker for ketamine’s antidepressant effect in treatment-resistant patients with major depression. Biol Psychiatry. 2015b;77:e19–20.

    CAS  PubMed  Google Scholar 

  • Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, et al. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res. 1994;643:40–9.

    CAS  PubMed  Google Scholar 

  • Zarrabi MH, Zucker S, Miller F, Derman RM, Romano GS, Hartnett JA, et al. Immunologic and coagulation disorders in chlorpromazine-treated patients. Ann Intern Med. 1979;91:194–9.

    CAS  PubMed  Google Scholar 

  • Zhou D, Kusnecov AW, Shurin MR, DePaoli M, Rabin BS. Exposure to physical and psychological stressors elevates plasma interleukin 6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology. 1993;133:2523–30.

    CAS  PubMed  Google Scholar 

  • Zhou AJ, Lee Y, Salvadore G, Hsu B, Fonseka TM, Kennedy SH, et al. Sirukumab: a potential treatment for mood disorders? Adv Ther. 2017;34:78–90.

    CAS  PubMed  Google Scholar 

  • Zhu J, Bengtsson BO, Mix E, Thorell LH, Olsson T, Link H. Effect of monoamine reuptake inhibiting antidepressants on major histocompatibility complex expression on macrophages in normal rats and rats with experimental allergic neuritis (EAN). Immunopharmacology. 1994;27:225–44.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The author thanks the foundation ‘Immunität & Seele’ for its support

Author information

Authors and Affiliations

  1. Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-Universität Munich, Munich, Germany

    Norbert Müller

Authors
  1. Norbert Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Norbert Müller .

Editor information

Editors and Affiliations

  1. Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy, University Hospital Wuerzburg, Wuerzburg, Germany

    Peter Riederer

  2. Institute of Psychological Medicine (IPM), Soyen, Germany

    Gerd Laux

  3. Centre for Research Promotion and Support, Fujita Health University, Toyoake, Aichi, Japan

    Toshiharu Nagatsu

  4. Center Translational Res Neurol Diseases, Dalian Med Uni Shanghai Inst Health Sc Center Translational Res Neurol Diseases, Dalian, China

    Weidong Le

  5. Würzburg, Germany

    Christian Riederer

Section Editor information

  1. University Hospital, Center for Mental Health, Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy, University Wuerzburg, Wuerzburg, Germany

    Peter Riederer

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Müller, N. (2022). Neurobiological Principles: Psycho-Neuro-Immuno-Endocrinology. In: Riederer, P., Laux, G., Nagatsu, T., Le, W., Riederer, C. (eds) NeuroPsychopharmacotherapy. Springer, Cham. https://doi.org/10.1007/978-3-030-62059-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-62059-2_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-62058-5

  • Online ISBN: 978-3-030-62059-2

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation